Renal effects of cyclo-oxygenase-type-2 inhibition.
Krämer
B K
BK
D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007676:Kidney Failure, Chronic / Q000139:chemically induced*; D011247:Pregnancy; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D015145:Tocolysis
D016861:Cyclooxygenase Inhibitors; D013449:Sulfonamides; C012655:nimesulide